Effect of State Legislation on Discharge Opioid Prescriptions After Total Hip and Knee Arthroplasties
- PMID: 33145384
- PMCID: PMC7593266
- DOI: 10.1016/j.artd.2020.08.003
Effect of State Legislation on Discharge Opioid Prescriptions After Total Hip and Knee Arthroplasties
Abstract
Background: Recent literature suggests that state-level legislation is effective in reducing postoperative opioid prescribing after total joint arthroplasty but has not addressed the effect on opioid antagonist coprescribing. This study aims to describe the change in postoperative opioid and opioid antagonist prescribing patterns after total joint arthroplasty following passage of state-level opioid-limiting legislation and to determine the comorbidities associated with increased opioid prescribing in this population.
Methods: Billing data were used to identify all patients who underwent primary total hip or knee arthroplasty admitted between March 2016 and March 2018 at our institution. The data were divided into 2 cohorts comprising the year before (671 subjects) and after (713 subjects) the legislation. Discharge prescriptions were reviewed, and the median morphine milligram equivalents (MME) per day and naloxone prescriptions were recorded. International Classification of Diseases codes were used to identify comorbid conditions of interest present during previous inpatient or outpatient encounters.
Results: There was a significant reduction in both the minimum and maximum median MME per day after introduction of state legislation and a substantial increase in opioid antagonist coprescription. Total knee arthroplasty, younger age, male sex, chronic pain disorders, post-traumatic stress disorder, and prior opioid abuse were correlated with increased opioid prescribing.
Conclusion: Our findings suggest that state-level legislation is effective in decreasing the MME per day prescribed and increasing opioid antagonist coprescription in the postoperative period for patients undergoing total hip and knee arthroplasties at our institution. These changes may lead to a decrease in opioid-related morbidity and mortality in the patient population undergoing total hip and knee arthroplasties.
Keywords: Arthroplasty; Legislation; Opioid; Prescription.
© 2020 The Authors.
Similar articles
-
Changes in opioid discharge prescriptions after primary total hip and total knee arthroplasty affect opioid refill rates and morphine milligram equivalents : an institutional experience of 20,000 patients.Bone Joint J. 2021 Jul;103-B(7 Supple B):103-110. doi: 10.1302/0301-620X.103B7.BJJ-2020-2392.R1. Bone Joint J. 2021. PMID: 34192916
-
Larger Initial Opioid Prescriptions Following Total Joint Arthroplasty Are Associated with Greater Risk of Prolonged Use.J Bone Joint Surg Am. 2021 Jan 20;103(2):106-114. doi: 10.2106/JBJS.20.00732. J Bone Joint Surg Am. 2021. PMID: 33074953
-
Effects of Opioid-Limiting Legislation in the State of Ohio on Opioid Prescriptions After Shoulder Arthroscopy.Orthop J Sports Med. 2023 Nov 20;11(11):23259671231202242. doi: 10.1177/23259671231202242. eCollection 2023 Nov. Orthop J Sports Med. 2023. PMID: 38021300 Free PMC article.
-
National and State Level Opioid-Restricting Legislation in Total Joint Arthroplasty: A Systematic Review.J Arthroplasty. 2022 Jan;37(1):176-185. doi: 10.1016/j.arth.2021.07.013. Epub 2021 Jul 31. J Arthroplasty. 2022. PMID: 34456092
-
Revision Arthroplasty Does Not Require More Opioids Than Primaries: A Review of Prescribing Practices After Implementation of a Structured Perioperative Pain Management Strategy.J Arthroplasty. 2020 Aug;35(8):2173-2176. doi: 10.1016/j.arth.2020.04.003. Epub 2020 Apr 14. J Arthroplasty. 2020. PMID: 32482474 Review.
Cited by
-
Effects of Opioid-Limiting Legislation and Increased Provider Awareness on Postoperative Opioid Use and Complications After Hip Arthroscopy.Orthop J Sports Med. 2023 May 1;11(5):23259671231162340. doi: 10.1177/23259671231162340. eCollection 2023 May. Orthop J Sports Med. 2023. PMID: 37152553 Free PMC article.
-
Use of a Non-Pharmacological Pain Relief Kit to Reduce Opioid Use Following Orthopedic Surgery: A Prospective Randomized Study.Int J Sports Phys Ther. 2022 Aug 1;17(5):915-923. doi: 10.26603/001c.36625. eCollection 2022. Int J Sports Phys Ther. 2022. PMID: 35949389 Free PMC article.
-
The Ramifications of Opioid Utilization and Outcomes of Alternative Pain Control Strategies for Total Knee Arthroplasties.Orthop Rev (Pavia). 2022 Aug 30;14(3):37496. doi: 10.52965/001c.37496. eCollection 2022. Orthop Rev (Pavia). 2022. PMID: 36045694 Free PMC article.
-
Opioid Cap Laws and Opioid Prescriptions After Total Joint Replacements in Older Adults.JAMA Netw Open. 2025 Apr 1;8(4):e254448. doi: 10.1001/jamanetworkopen.2025.4448. JAMA Netw Open. 2025. PMID: 40202758 Free PMC article.
-
Impact of state legislation and institutional protocols on opioid prescribing practices following pediatric tonsillectomy.Laryngoscope Investig Otolaryngol. 2023 May 24;8(3):775-785. doi: 10.1002/lio2.1074. eCollection 2023 Jun. Laryngoscope Investig Otolaryngol. 2023. PMID: 37342116 Free PMC article.
References
-
- American Academy of Orthopaedic Surgeons Treatment of osteoarthritis of the knee: evidence-based guideline, 2nd edition. J Am Acad Orthop Surg. 2013;21:571. - PubMed
-
- Kurtz S., Ong K., Lau E., Mowat F., Halpern M. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007;89(4):780. - PubMed
-
- Bates C., Laciak R., Southwick A., Bishoff J. Overprescription of postoperative narcotics: a look at postoperative pain medication delivery, consumption and disposal in urological practice. J Urol. 2011;185(2):551. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous